Measurement of IgE to hazelnut allergen components cannot replace hazelnut challenge in Dutch adults
- PMID: 34731517
- PMCID: PMC9298907
- DOI: 10.1111/all.15166
Measurement of IgE to hazelnut allergen components cannot replace hazelnut challenge in Dutch adults
Abstract
Background: Component-resolved diagnostics (CRD) help predict hazelnut allergy (HA) in children, but are of unknown diagnostic value in adults. This study aimed to evaluate the diagnostic accuracy of IgE to hazelnut extract and components in adults.
Methods: A Dutch population of consecutively presenting adults suspected of HA, who underwent a double-blind placebo-controlled food challenge, were included. Serum IgE to hazelnut extract and Cor a 1, 8, 9, and 14 was measured on ImmunoCAP. Diagnostic accuracy was assessed by area under the curve (AUC) analysis.
Results: Of 89 patients undergoing challenge, 46 had challenge-confirmed HA: 17 based on objective and 29 based on subjective symptoms. At commonly applied cutoffs 0.1 and 0.35 kUA /L, high sensitivity was observed for IgE to hazelnut extract and Cor a 1 (range 85-91%), and high specificity for IgE to Cor a 8, 9 and 14 (range 77-95%). However, the AUCs for hazelnut extract and components were too low for accurate prediction of HA (range 0.50-0.56). Combining hazelnut extract and component IgE measurements did not significantly improve accuracy. Higher IgE levels to Cor a 9 and 14 were tentatively associated with HA with objective symptoms, but the corresponding AUCs still only reached 0.68 and 0.63, respectively.
Conclusions: Although hazelnut allergic adults are generally sensitized to hazelnut extract and Cor a 1, and hazelnut tolerant adults are usually not sensitized to Cor a 8, 9, or 14, challenge testing is still needed to accurately discriminate between presence and absence of HA in adults from a birch-endemic country.
Keywords: IgE; adults; component-resolved diagnostics; diagnostic value; hazelnut allergy.
© 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Conflict of interest statement
ImmunoCAP material was provided by Thermo Fisher Scientific. All authors declare no further conflicts of interest in relation to this study. Outside submitted work, Dr. Knol reports personal fees from Thermo Fisher Scientific, and Dr. Van Ree reports personal fees from HAL Allergy BV, Citeq BV, Angany Inc., Thermo Fisher Scientific; and grants from the Dutch Science Foundation, European Commission, and Health Holland.
Figures


References
-
- Lyons SA, Burney PGJ, Ballmer‐Weber BK, et al. Food Allergy in Adults: Substantial Variation in Prevalence and Causative Foods Across Europe. J Allergy Clin Immunol Pract. 2019;7(6):1920‐1928. e11 - PubMed
-
- Woods RK, Abramson M, Bailey M, Walters EH. International prevalences of reported food allergies and intolerances. Comparisons arising from the European Community Respiratory Health Survey (ECRHS) 1991–1994. Eur J Clin Nutr. 2001;55(4):298‐304. - PubMed
-
- McWilliam V, Koplin J, Lodge C, Tang M, Dharmage S, Allen K. The Prevalence of Tree Nut Allergy: A Systematic Review. Curr Allergy Asthma Rep. 2015;15(9):54. - PubMed
-
- McWilliam VL, Perrett KP, Dang T, Peters RL. Prevalence and natural history of tree nut allergy. Ann Allergy Asthma Immunol. 2020;124(5):466‐472. - PubMed
-
- Bindslev‐Jensen C, Ballmer‐Weber BK, Bengtsson U, et al. Standardization of food challenges in patients with immediate reactions to foods ‐ position paper from the European Academy of Allergology and Clinical Immunology. Allergy. 2004;59(7):690‐697. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources